Published in Cancer Weekly, April 6th, 2004
According to recent research from Greece, "The aim of this study was to investigate by an in situ hybridization procedure the telomerase expression as a marker in prostate cancer and to correlate these results with several prognostic factors concerning this cancer.
"Imprint smear samples were obtained from 70 prostates removed from patients who underwent radical prostatectomy for prostate adenocarcinoma. Telomerase expression in cancerous prostate smears was studied using an in situ hybridization...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.